AI News

    Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

    The DeepMind spinout secures a $5 billion Series C to advance its drug-discovery ambitions.

    Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.

    TA

    TechCrunch AI

    Source

    TechCrunch AI
    Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
    AI Analysis

    Generated insight by OnAirToday AI

    A $5 billion Series C gives Isomorphic Labs substantial backing for its effort to advance drug candidates toward clinical trials. The company’s origins at DeepMind connect its drug-discovery work to a prominent AI research organization.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at TechCrunch AI →
    Share
    Filed under:AI News

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000